Citadel Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,053	Closed	-$100K	–	7475
2021 Q4	$100K	Hold	10,053	–	–	﹤0.01%	5911
2021 Q3	$101K	Sell	10,053 -1,115	-10%	-$11.2K	﹤0.01%	5866
2021 Q2	$114K	Buy	+11,168	New	+$114K	﹤0.01%	5902